Rheumatoid Arthritis
Showing NaN - NaN of 101
Rheumatoid Arthritis Trial in Worldwide (PF-05280586, MabThera, Rituxan)
Completed
- Rheumatoid Arthritis
- PF-05280586
- +2 more
-
Birmingham, Alabama
- +83 more
Oct 30, 2019
Rheumatoid Arthritis Trial in Worldwide (Baricitinib, Methotrexate, Baricitinib Placebo)
Rheumatoid Arthritis Trial in Worldwide (Adalimumab, Baricitinib, Methotrexate)
Rheumatoid Arthritis Trial in Worldwide (Leflunomide, Methotrexate, Ocrelizumab)
Osteoarthritis, Avascular Necrosis, Rheumatoid Arthritis Trial in United States (Cormet Hip Resurfacing)
Completed
- Osteoarthritis
- +2 more
- Cormet Hip Resurfacing
-
Washington, District of Columbia
- +5 more
Jun 12, 2019
Rheumatoid Arthritis Trial in Worldwide (Etanercept, CHS-0214)
Completed
- Rheumatoid Arthritis
-
Phoenix, Arizona
- +140 more
Jun 7, 2019
Rheumatoid Arthritis Trial in Puerto Rico, United States (Itacitinib, Itacitinib Placebo)
Completed
- Rheumatoid Arthritis
- Itacitinib
- Itacitinib Placebo
-
Palm Desert, California
- +17 more
Mar 8, 2019
Rheumatoid Arthritis Trial in Worldwide (Rituximab-Pfizer (PF-05280586) x 3 courses, Rituximab-EU+ Rituximab-Pfizer x 2 Courses,
Completed
- Rheumatoid Arthritis
- Rituximab-Pfizer (PF-05280586) x 3 courses
- +2 more
-
Birmingham, Alabama
- +70 more
Jan 8, 2019
Rheumatoid Arthritis Trial in Worldwide (Adalimumab - GP2017, Adalimumab - US licensed Humira)
Completed
- Rheumatoid Arthritis
- Adalimumab - GP2017
- Adalimumab - US licensed Humira
-
Mesa, Arizona
- +82 more
Nov 30, 2018
Inflammation, Rheumatoid Arthritis Trial in Worldwide (NNC0109-0012, )
Terminated
- Inflammation
- Rheumatoid Arthritis
- NNC0109-0012
- placebo
-
Huntsville, Alabama
- +163 more
Sep 3, 2018
Rheumatoid Arthritis, Psoriatic Arthritis Trial in United States (Etanercept / Autoinjector A)
Completed
- Rheumatoid Arthritis
- Psoriatic Arthritis
- Etanercept / Autoinjector A
-
Huntsville, Alabama
- +12 more
Aug 1, 2018
Rheumatoid Arthritis, Plaque Psoriasis Trial in Canada, United States (Etanercept via Autoinjector A, Etanercept via
Completed
- Rheumatoid Arthritis
- Plaque Psoriasis
- Etanercept via Autoinjector A
- Etanercept via Autoinjector B
-
Huntsville, Alabama
- +36 more
Aug 1, 2018
Rheumatoid Arthritis Trial in Worldwide (Certolizumab Pegol)
Completed
- Rheumatoid Arthritis
- Certolizumab Pegol
-
Huntsville, Alabama
- +60 more
Jul 4, 2018
Rheumatoid Arthritis Trial in Worldwide (Certolizumab pegol (CZP), Placebo)
Completed
- Rheumatoid Arthritis
- Certolizumab pegol (CZP)
- Placebo
-
Birmingham, Alabama
- +180 more
Jul 4, 2018
Rheumatoid Arthritis Trial in United States (Certolizumab Pegol (CZP))
Completed
- Rheumatoid Arthritis
- Certolizumab Pegol (CZP)
-
Birmingham, Alabama
- +109 more
Jul 4, 2018
Rheumatoid Arthritis Trial in United States (Adalimumab delivered in current syringe, Adalimumab delivered in Physiolis syringe,
Completed
- Rheumatoid Arthritis
- Adalimumab delivered in current syringe
- +3 more
-
Victorville, California
- +9 more
Jun 1, 2018
Rheumatoid Arthritis Trial in Worldwide (LY2127399, Placebo Q4W, Placebo Q2W)
Rheumatoid Arthritis Trial in Worldwide (LY2127399, Placebo Q2W, Placebo Q4W)
Rheumatoid Arthritis Trial in United States (Tofacitinib, Placebo)
Rheumatoid Arthritis Trial in Worldwide (GP2013 - A Proposed biosimilar rituximab, Originator rituximab - Rituxan ® or MabThera
Completed
- Rheumatoid Arthritis
- GP2013 - A Proposed biosimilar rituximab
- Originator rituximab - Rituxan ® or MabThera ®
-
Huntsville, Alabama
- +64 more
Nov 30, 2017